Catalent
CTLT
#1737
Rank
โ‚น1.036 T
Marketcap
โ‚น5,709
Share price
0.00%
Change (1 day)
20.86%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น569.27. In 2023 the company made an earnings per share (EPS) of -โ‚น611.54 a decrease over its 2022 EPS that were of โ‚น204.15.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-13.8%
2023-โ‚น611.54-399.56%
2022โ‚น204.15-30.58%
2021โ‚น294.0879.67%
2020โ‚น163.68114.12%
2019โ‚น76.44-15%
2018โ‚น89.9375.44%
2017โ‚น51.26-22.97%
2016โ‚น66.55-59.56%
2015โ‚น164.58282.05%
2014โ‚น43.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น29.68-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.45-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น536.00-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-โ‚น133.10-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA